AJCN Tufts Nutrition Symposium, Boston Sept 24-26
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rayman, M. P
Right arrow Articles by Beckett, G. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rayman, M. P
Right arrow Articles by Beckett, G. J
Agricola
Right arrow Articles by Rayman, M. P
Right arrow Articles by Beckett, G. J
American Journal of Clinical Nutrition, Vol. 87, No. 2, 370-378, February 2008
© 2008 American Society for Nutrition

ORIGINAL RESEARCH COMMUNICATION

Randomized controlled trial of the effect of selenium supplementation on thyroid function in the elderly in the United Kingdom1,2,3,4

Margaret P Rayman, Alexander J Thompson, Bram Bekaert, Janet Catterick, Rachel Galassini, Emma Hall, Margaret Warren-Perry and Geoffrey J Beckett

1 From the Nutritional Sciences Division, Faculty of Health and Medical Sciences, University of Surrey, Guildford United Kingdom (MPR, AJT, BB, JC, RG, and MW-P); Clinical Trials & Statistics Unit, Section of Clinical Trials, Institute of Cancer Research, Sutton, United Kingdom (EH); Clinical Biochemistry, University of Edinburgh, The Royal Infirmary of Edinburgh, Edinburgh, United Kingdom (GJB)

Background:Thyroid function depends on the essential trace mineral selenium, which is at the active center of the iodothyronine deiodinase enzymes that catalyze the conversion of the prohormone thyroxine (T4) to the active form of thyroid hormone, triiodothyronine (T3).

Objective:Because selenium intake in the United Kingdom has fallen during the past 25 y, we wanted to determine whether current selenium status might be limiting conversion of T4 to T3 in the elderly, in whom marginal hypothyroidism is relatively common.

Design:We investigated the effect of selenium supplementation in a double-blind, placebo-controlled trial in 501 elderly UK volunteers. Similar numbers of men and women from each of 3 age groups, 60–64 y, 65–69 y, and 70–74 y, were randomly allocated to receive 100, 200, or 300 µg Se/d as high-selenium yeast or placebo yeast for 6 mo. As part of the study, plasma selenium, thyroid-stimulating hormone, and total and free T3 and T4 were measured. Data from 368 euthyroid volunteers who provided blood samples at baseline and 6 mo were analyzed.

Results:Although selenium status at baseline correlated weakly with free T4 (r = –0.19, P < 0.001) and with the ratio of free T3 to free T4 (r = 0.12, P = 0.02), we found no evidence of any effect of selenium supplementation on thyroid function, despite significant increases in plasma selenium. However, baseline plasma selenium in our study (x: 91 µg/L) was somewhat higher than in previous supplementation studies in which apparently beneficial effects were seen.

Conclusion:We found no indication for increasing selenium intake to benefit T4 to T3 conversion in the elderly UK population.

Key Words: Selenium • thyroid • T3 • T4 • randomized controlled trial • UK elderly






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The American Society for Nutrition